Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

252

HTML

2589

Figures (1-2)

170

Tables (1-2)

184

Sum=3195

Feb 15, 2001 (publication date) through Dec 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 15, 2001; 7(1): 136-139
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.136

Table 1 Methylation status of c-fms oncogene (number of patients)

Note: χ² = 4.36, P < 0.05, hypomethylation rate of c-fms oncogene in HCC tissue was higher than that in circum-cancer liver tissue.

Citation: Cui J, Yang DH, Bi XJ, Fan ZR. Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology. World J Gastroenterol 2001; 7(1): 136-139
URL: https://www.wjgnet.com/1007-9327/full/v7/i1/136.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i1.136